OncoGenex Pharmaceuticals, Inc. announced today that it has filed a shelf registration statement on Form S-3 with the US Securities and Exchange Commission and an MJDS prospectus under the multi-jurisdictional disclosure system in the Province of British Columbia.
OncoGenex Pharmaceuticals files shelf registration statement